SCIENCE-FOR-THE-PEOPLE Archives

November 2011

SCIENCE-FOR-THE-PEOPLE@LIST.UVM.EDU

Options: Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
Jim West <[log in to unmask]>
Reply To:
Science for the People Discussion List <[log in to unmask]>
Date:
Tue, 15 Nov 2011 23:30:19 -0500
Content-Type:
text/plain
Parts/Attachments:
text/plain (18 lines)
Why do people by Glaxo product$ (vaccine$, pharma, etc)?  Great adverti$ing!

http://www.pharmalot.com/2011/11/glaxo-to-pay-3b-to-settle-marketing-
probes/
 
In the largest settlement of its kind involving a drugmaker, GlaxoSmithKline has 
agreed to pay $3 billion to resolve a trio of US investigations into its sales, 
marketing and pricing practices dating back more than a decade. The deal, which 
is expected to be finalized, some time next year, would settle both civil and 
criminal charges...

This is the second time in the past year, by the way, that Glaxo has struck a deal 
to resolve federal charges of bad behavior. In June, the drugmaker agreed to pay 
$40.8 million to 37 US states and the District of Columbia. This was on top of a 
$750 million payment to settle criminal and civil charges related to numerous 
production problems - contaminated meds, mislabeled packaging and incorrect 
dosages... 

ATOM RSS1 RSS2